Antiaging Quantum Living Income Statement (2020-2025) | AAQL

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.00M400.000.00M0.00M0.00M0.00M0.00M0.00M0.01M0.00M0.00M0.00M0.01M0.20M0.17M0.15M0.29M0.29M0.39M0.34M
Cost of Revenue (Quarter) 300.00500.00600.00500.00760.000.07M165.000.10M0.01M-0.14M0.01M0.07M0.14M
Gross Profit (Quarter) 100.000.00M0.00M0.00M0.00M900.000.00M0.01M0.00M0.00M0.00M0.01M-11.000.20M0.16M0.15M-0.08M0.23M0.32M0.20M
Operating items
Selling, General & Administrative (Quarter) 0.03M0.02M0.01M0.01M0.02M0.01M0.02M0.02M0.01M0.01M0.01M0.03M0.02M0.09M0.20M0.28M0.26M0.28M0.24M0.36M0.35M0.40M
Other Operating Expenses (Quarter) 0.01M0.06M0.13M0.10M0.06M-0.14M0.01M0.03M0.08M
Operating Expenses (Quarter) 0.03M0.02M0.01M0.01M0.02M0.01M0.02M0.02M0.01M0.01M0.01M0.03M0.02M0.10M0.26M0.42M0.36M0.35M0.10M0.37M0.38M0.48M
Operating Income (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.20M-0.18M-0.14M-0.05M-0.27M
EBIT (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.20M-0.18M-0.14M-0.05M-0.27M
Non-operating items
Interest & Investment Income (Quarter) 0.00M882.00882.00863.00873.00701.002.0043.0025.0022.0014.0018.0021.0012.0073.00
Other Non Operating Income (Quarter) 0.00M1.000.07M-175.000.01M57.0053.00
Non Operating Income (Quarter) 0.00M882.00882.00863.00873.00701.00-2.0025.0022.000.07M-236.000.01M69.00126.00
Net income details
EBT (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.05M-0.27M
Tax Provisions (Quarter) 0.01M0.01M55.00
Profit After Tax (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M
Income from Continuing Operations (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M
Consolidated Net Income (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M
Income towards Parent Company (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M
Net Income towards Common Stockholders (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.20M-0.13M-0.18M-0.13M-0.06M-0.27M
Additional items
EPS (Basic) (Quarter) 0.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.01-0.01-0.010.00-0.010.000.00-0.01
EPS (Weighted Average and Diluted) (Quarter) 0.000.000.000.000.000.000.00-0.01-0.01-0.010.00-0.010.000.00-0.01
Shares Outstanding (Weighted Average) (Quarter) 30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M29.95M30.00M30.00M30.57M
Shares Outstanding (Diluted Average) (Quarter) 30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M30.00M29.95M30.00M30.00M31.72M
EBITDA (Quarter) -0.03M-0.02M-0.01M-0.01M-0.01M-0.01M-0.02M-0.02M-0.00M-0.01M-0.01M-0.03M-0.02M-0.10M-0.26M-0.21M-0.22M-0.10M-0.18M-0.14M-0.06M-0.25M
Tax Rate (Quarter) -4.71%-20.42%-0.02%